However, exosomes, which are small extracellular vesicles (40–150 nm) released during the fusion of multivesicular bodies with the plasma membrane, have therapeutic potential to control KRAS-dependent pancreatic cancer [24,25]. Here, KRAS is linked to pancreatic neoplasm.